Children’s Primary Sclerosing Cholangitis

University of Minnesota
Trials underway

Primary Sclerosing Cholangitis is a devastating disease in which inflammation and scarring in the bile ducts lead to liver damage. The average life expectancy after diagnosis of PSC is 10-20 years. Researchers at the University of Minnesota are completing a pilot trial with microbiota transplants to test safety in this population and direct the development of future studies. This trial is currently recruiting patients. More trial information and eligibility criteria are available here.